Toso Company, Limited
Toso Company, Limited (5956.T) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Toso Company, Limited (5956.T), covering cash flow, earnings, and balance sheets.
Toso Company, Limited (5956.T) Income Statement & Financial Overview
View the income breakdown for Toso Company, Limited 5956.T across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $6.33B | $5.93B | $5.53B | $5.001B |
| Cost of Revenue | $3.81B | $3.52B | $3.28B | $3.00B |
| Gross Profit | $2.52B | $2.36B | $2.20B | $1.96B |
| Gross Profit Ratio | $0.40 | $0.40 | $0.40 | $0.39 |
| R&D Expenses | $6.88M | $4.00M | $7.00M | $3.00M |
| SG&A Expenses | $2.12B | $2.00B | $2.06B | $2.09B |
| Operating Expenses | $2.13B | $2.06B | $2.07B | $2.14B |
| Total Costs & Expenses | $5.94B | $5.57B | $5.40B | $5.14B |
| Interest Income | $4.41M | $4.63M | $0.00 | $12.00M |
| Interest Expense | $9.54M | $7.27M | $6.82M | $0.00 |
| Depreciation & Amortization | $184.18M | $132.75M | -$2.97M | $132.75M |
| EBITDA | $568.89M | $491.75M | $130.36M | -$3.25M |
| EBITDA Ratio | $0.09 | $0.08 | $0.02 | -$0.001 |
| Operating Income | $390.38M | $358.00M | $133.33M | -$136.00M |
| Operating Income Ratio | $0.06 | $0.06 | $0.02 | -$0.03 |
| Other Income/Expenses (Net) | -$15.22M | $28.00M | -$9.79M | $24.00M |
| Income Before Tax | $375.16M | $386.00M | $123.53M | -$112.00M |
| Income Before Tax Ratio | $0.06 | $0.07 | $0.02 | -$0.02 |
| Income Tax Expense | $108.04M | $113.00M | $50.44M | -$3.04M |
| Net Income | $265.27M | $271.00M | $71.95M | -$109.00M |
| Net Income Ratio | $0.04 | $0.05 | $0.01 | -$0.02 |
| EPS | $29.97 | $30.52 | $7.98 | -$12.11 |
| Diluted EPS | $29.97 | $30.52 | $7.98 | -$12.11 |
| Weighted Avg Shares Outstanding | $8.87M | $8.88M | $9.01M | $9.00M |
| Weighted Avg Shares Outstanding (Diluted) | $8.87M | $8.88M | $9.01M | $9.00M |
The company's financials show resilient growth, with revenue advancing from $5.001B in Q1 2024 to $6.33B in Q4 2024. Gross profit remained healthy with margins at 40% in Q4 2024 compared to 39% in Q1 2024. Operating income hit $390.38M last quarter, sustaining a consistent 6% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $568.89M. Net income dropped to $265.27M, while earnings per share reached $29.97. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan